Anping Lai

Title: The Innovations of Anping Lai in Alzheimer's Treatment

Introduction

Anping Lai, located in Taizhou, China, is an accomplished inventor known for his significant contribution to the field of pharmaceuticals. With one patent to his name, he has made a notable impact in the development of treatments for Alzheimer's disease.

Latest Patents

Anping Lai holds a patent for the "Preparation method of rivastigmine, its intermediates and preparation method of the intermediates." This invention pertains to a chemical compound represented by formula (II), specifically N-methylethylcarbamino-3-[(S)-1-(methyl-[(S)-1-phenylethyl]amino)ethyl]phenyl ester. The patent also details the synthesis of key intermediates vital for the compound, namely (S)-1-(3-methoxyphenyl)-N-methyl-N-[(S)-1-phenylethyl]ethylamine and 3-[(S)-1-(methyl-[(S)-1-phenylethyl]amino)ethyl]phenol. The application of this compound is intended for the preparation of rivastigmine, which is specifically used in the treatment of Alzheimer's disease.

Career Highlights

Anping Lai has worked at several notable companies including the Shanghai Institute of Pharmaceutical Industry and Zhejiang Hisun Pharmaceutical Co., Ltd. His tenure at these organizations has allowed him to hone his expertise in pharmaceutical innovations, particularly in drug formulation and development.

Collaborations

Throughout his career, Anping Lai has collaborated with talented colleagues such as Fuli Zhang and Meng Hu. These partnerships have enriched his research and contributed to the advancement of pharmaceutical sciences, particularly in the area of neurodegenerative diseases.

Conclusion

Anping Lai’s contributions to the field of pharmacology showcase his dedication to addressing complex medical challenges. With his patent focused on Alzheimer's treatment, he remains a notable figure in pharmaceutical innovation, demonstrating the importance of collaboration and research in advancing healthcare solutions.